10-QPYXSCIK 0001782223

Pyxis Oncology, Inc.

Name: SEC EDGAR filing 0001193125-26-347913
Creator: Pyxis Oncology, Inc.
License: https://www.usa.gov/government-works

Quarterly report (10-Q) filed August 13, 2026.

Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters.

Read the filing on SEC.gov All documents in this filing

New to the 10-Q? What it is and how to read one

Filing facts

Accession number: 0001193125-26-347913
Filer: Pyxis Oncology, Inc.
Ticker: PYXS
CIK: 0001782223
Form type: 10-Q
Form description: Quarterly report
Filed at: August 13, 2026
Period of report: June 30, 2026
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 9.4 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Pyxis Oncology, Inc.

See all 45 filings from Pyxis Oncology, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1782223/000119312526347913/0001193125-26-347913-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Pyxis Oncology, Inc. (0001782223) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.